JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 28, 2007; DOI: 10.1124/jpet.107.124719


0022-3565/07/3232-675-683$20.00
JPET 323:675-683, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.124719v1
323/2/675    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buchweitz, J. P.
Right arrow Articles by Kaminski, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buchweitz, J. P.
Right arrow Articles by Kaminski, N. E.

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Modulation of Airway Responses to Influenza A/PR/8/34 by {Delta}9-Tetrahydrocannabinol in C57BL/6 Mice

John P. Buchweitz, Peer W. F. Karmaus, Jack R. Harkema, Kurt J. Williams, and Norbert E. Kaminski

Departments of Pharmacology and Toxicology (J.P.B., N.E.K) and Pathobiology and Diagnostic Investigation (J.R.H., K.J.W.) and Center for Integrative Toxicology (J.P.B., P.W.F.K., J.R.H, N.E.K.), Michigan State University, East Lansing, Michigan

{Delta}9-Tetrahydrocannabinol ({Delta}9-THC) has been widely established as a modulator of host immune responses. Accordingly, the objective of the present study was to examine the effects of {Delta}9-THC on the immune response within the lungs and associated changes in the morphology of the bronchiolar epithelium after one challenge with a nonlethal dose of the influenza virus A/PR/8 (PR8). C57BL/6 mice were treated by oral gavage with {Delta}9-THC and/or vehicle (corn oil) for 5 consecutive days. On day 3, mice were instilled intranasally with 50 plaque-forming units of PR8 and/or vehicle (saline) 4 h before {Delta}9-THC exposure. Mice were subsequently killed 7 and 10 days postinfection (dpi). Viral hemagglutinin 1 (H1) mRNA levels in the lungs were increased in a dose-dependent manner with {Delta}9-THC treatment. Enumeration of inflammatory cell types in bronchoalveolar lavage fluid showed an attenuation of macrophages and CD4+ and CD8+ T cells in {Delta}9-THC-treated mice compared with controls. Likewise, the magnitude of inflammation and virus-induced mucous cell metaplasia, as assessed by histopathology, was reduced in {Delta}9-THC-treated mice by 10 dpi. Collectively, these results suggest that {Delta}9-THC treatment increased viral load, as assessed by H1 mRNA levels, through a decrease in recruitment of macrophages and lymphocytes, particularly CD4+ and CD8+ T cells, to the lung.


Received April 20, 2007; accepted August 27, 2007.

Address correspondence to: Dr. Norbert E. Kaminski, 315 National Food Safety and Toxicology Building, Michigan State University, East Lansing, MI 48824-1317. E-mail address: kamins11{at}msu.edu




This article has been cited by other articles:


Home page
ChestHome page
J. A. Voynow and B. K. Rubin
Mucins, Mucus, and Sputum
Chest, February 1, 2009; 135(2): 505 - 512.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Lu, B. L. F. Kaplan, T. Ngaotepprutaram, and N. E. Kaminski
Suppression of T cell costimulator ICOS by {Delta}9-tetrahydrocannabinol
J. Leukoc. Biol., February 1, 2009; 85(2): 322 - 329.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Iribarne, V. Torbidoni, K. Julian, J. P. Prestifilippo, D. Sinha, V. Rettori, A. Berra, and A. M. Suburo
Cannabinoid Receptors in Conjunctival Epithelium: Identification and Functional Properties
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4535 - 4544.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. P. Buchweitz, P. W. F. Karmaus, K. J. Williams, J. R. Harkema, and N. E. Kaminski
Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of {Delta}9-tetrahydrocannabinol
J. Leukoc. Biol., March 1, 2008; 83(3): 785 - 796.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.